Health-related quality of life (HRQL) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel (CBZ) in a prospective observational study (CAPRISTANA)

Autor:	Joseph Makdessi, Irina Koroleva, Angelika Pichler, F. El Karak, Gisoo Barnes, Antoaneta Tomova, Hana Korunkova, Joan Carles, Simon Hitier, Jana Katolicka, Marwan Ghosn, Ayse Ozatilgan
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty business.industry Hematology Castration resistant medicine.disease Prostate cancer Quality of life Cabazitaxel Internal medicine medicine Observational study In patient business medicine.drug
Zdroj:	Annals of Oncology. 28:v281
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx370.029
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::04977f373faa33fb922fa9084b82ec3f https://doi.org/10.1093/annonc/mdx370.029 Zobrazit plný text záznamu